PROTECTIVE EFFECTS OF PROPIONYL-L-CARNITINE DURING ISCHEMIA AND REPERFUSION

被引:32
作者
SHUG, A
PAULSON, D
SUBRAMANIAN, R
REGITZ, V
机构
[1] UNIV WISCONSIN,SCH MED,MADISON,WI 53706
[2] SCH OSTEOPATH MED,CHICAGO,IL
[3] HERZZENTRUM,BERLIN,GERMANY
关键词
PROPIONYL-L-CARNITINE; ISCHEMIA; REPERFUSION FATTY ACIDS; FREE RADICALS;
D O I
10.1007/BF00128246
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
When cardiac function in isolated rat hearts was impaired by subject them to ischemia, subsequent perfusion with propionyl-L-carnitine and related compounds increased their rate of recovery. Thus at 11 mM, both propionyl-L-carnitine and, to a lesser extent, its taurine amide, and also acetyl-L-carnitine, significantly restored cardiac function in 15 minutes after 90 minutes of either low-flow or intermittent no-flow ischemia. Carnitine itself was ineffective. Propionyl-L-carnitine also increased tissue ATP and creatine phosphate compared with controls, but did not affect the levels of long-chain acyl carnitine and coenzyme. These esters also depleted fatty acid peroxidation, as shown with malonaldehyde, and were more effective than carnitine in preventing the production of superoxide. In myocytes, propionyl-L-carnitine alone stimulated palmitate oxidation, but in rat heart homogenates, both L-carnitine and propionyl-L-carnitine did so, while acetyl-L-carnitine was actually inhibitory. Possible mechanisms for the protective action of propionyl-L-carnitine against ischemia include an increased rate of cellular transport, stimulation of fatty acid oxidation, and a reduction of free radical formation.
引用
收藏
页码:77 / 84
页数:8
相关论文
共 34 条
[1]  
Folts J.D., Shug A.L., Koke J.R., Bittar N., Protection of the ischemic dog myocardium with carnitine, Am J Cardiol, 41, pp. 1209-1214, (1978)
[2]  
Suzuki Y., Kamikawa T., Kobayashi A., Et al., Effects of L-carnitine on tissue levels of acyl carnitine, acyl coenzyme A and high energy phosphate in ischemic dog hearts, Jpn Circ J, 45, pp. 687-694, (1981)
[3]  
Liedtke A.J., Nellis S.H., Copenhaver G., Effects of carnitine in ischemic and fatty acid supplemented swine hearts, J Clin Invest, 64, pp. 440-447, (1979)
[4]  
Liedtke A.J., Nellis S.H., Whitesell L.G., Effect of carnitine isomers on fatty acid metabolism in ischemic swine hearts, Circ Res, 48, pp. 859-866, (1981)
[5]  
Liedtke A.J., Vary T.C., Nellis S.H., Fultz C.W., Properties of carnitine incorporation in working swine hearts, Circ Res, 50, pp. 767-774, (1982)
[6]  
Suzuki Y., Kamikawa T., Yamazaki N., Effects of L-carnitine on ventricular arrhythmias in dogs with acute myocardial ischemia and supplement of excess free fatty acids, Jpn Cir J, 45, pp. 552-559, (1981)
[7]  
Kotaka J., Miyazaki Y., Ogawa K., Et al., Protection by carnitine against free fatty acid-induced arrhythmia in canine heart, J Appl Biochem, 3, pp. 292-300, (1981)
[8]  
Suzuki Y., Narita M., Yamazaki N., Effects of L-carnitine on arrhythmias during hemodialysis, Jpn Heart J, 23, pp. 349-359, (1981)
[9]  
Di Palma J.R., Ritchie D.M., McMichael R.F., Cardiovascular and antiarrhythmic effects of carnitine, Arch Int Pharmacodyn, 217, pp. 246-250, (1975)
[10]  
Thoen J.H., Shug A.L., Yap V.U., Et al., Improved pacing tolerance of the ischemic human myocardium after administration of carnitine, Am J Cardiol, 43, pp. 300-306, (1979)